← back to search

Chrysoula Belessi

General Hospital of Nikea ·
Area of research
Genetics · Pathology and Forensic Medicine
Research interest
Research interests include Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, and Monoclonal and Polyclonal Antibodies Research.
h-index
35
citations
5,073
works
162
NIH funding
primary concept
Chronic lymphocytic leukemia
email

Recent publications

Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories
Frontiers in Oncology 2023cited by 13position: middledoi
Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL
Leukemia 2022cited by 79position: middledoi
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
Blood 2020cited by 129position: middledoi
Disease‐biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations
The Journal of Pathology 2018cited by 32position: middledoi
Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations
Leukemia 2017cited by 140position: middledoi
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes
Clinical Cancer Research 2017cited by 35position: middledoi
EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia
Leukemia 2016cited by 53position: middledoi
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations
Blood 2015cited by 153position: middledoi
Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
The Journal of Experimental Medicine 2015cited by 99position: middledoi
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations
Blood 2015cited by 81position: middledoi
EGR2 Mutations in Chronic Lymphocytic Leukemia: A New Bad Player
Blood 2015cited by 0position: middledoi
Recurrent mutations refine prognosis in chronic lymphocytic leukemia
Leukemia 2014cited by 276position: middledoi
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study
The Lancet Haematology 2014cited by 112position: middledoi
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
Blood 2012cited by 387position: middledoi
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications
Leukemia 2012cited by 123position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Andreas Agathangelidis · National and Kapodistrian University of Athens3 papers (2017–2023)Κώστας Σταματόπουλος · Karolinska Institutet3 papers (2017–2023)Anton W. Langerak · Erasmus MC2 papers (2017–2022)Paolo Ghia · Vita-Salute San Raffaele University2 papers (2017–2022)Véronique Giudicelli · National Council for Scientific Research2 papers (2017–2022)Frédéric Davi · Université Sorbonne Nouvelle2 papers (2017–2022)Richard Rosenquist · Karolinska University Hospital2 papers (2017–2022)Marco Ladetto · Università degli Studi del Piemonte Orientale “Amedeo Avogadro”1 papers (2023–2023) · 1 papers (2023–2023)Sofia Kossida · National Council for Scientific Research1 papers (2022–2022)Anastasia Hadzidimitriou · Science for Life Laboratory1 papers (2017–2017)Simone Ferrero · Centro de Investigación Biomédica en Red de Cáncer1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2023–2023)Cristina Jiménez · Universidad de Salamanca1 papers (2023–2023)Anastasia Chatzidimitriou · Karolinska Institutet1 papers (2022–2022) · 1 papers (2023–2023)Panagiotis Baliakas · Uppsala University1 papers (2017–2017)Evdoxia Hatjiharissi · AHEPA University Hospital1 papers (2023–2023)Evangelos Terpos · Frontier Science Foundation-Hellas1 papers (2023–2023)